Medha Satyarengga1, Tariq Siddiqui1,2, Elias K Spanakis3,4. 1. Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, 827 Linden Avenue, Baltimore, MD, 21201, USA. 2. Division of Endocrinology, Baltimore Veterans Affairs Medical Center, 10 N. Greene Street, Baltimore, MD, 21201, USA. 3. Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, 827 Linden Avenue, Baltimore, MD, 21201, USA. ispanakis@som.umaryland.edu. 4. Division of Endocrinology, Baltimore Veterans Affairs Medical Center, 10 N. Greene Street, Baltimore, MD, 21201, USA. ispanakis@som.umaryland.edu.
Abstract
PURPOSE OF THE REVIEW: Hospitalized patients with diabetes are monitored with point-of-care glucose testing. Continuous glucose monitoring (CGM) devices represent an alternative way to monitor glucose values; however, the in-hospital CGM use is still considered experimental. Most inpatient studies used "blinded" CGM properties and only few used the real-time/unblinded CGM features. One major limitation of the CGM devices is that they need to be placed at the patients' bedside, limiting any therapeutic interventions. In this article, we review the real-time/unblinded CGM use and share our thoughts about the development of future inpatient CGM systems. RECENT FINDINGS: We recently reported that glucose values can be wirelessly transmitted to the nursing station, providing remote continuous glucose monitoring. Future inpatient CGM devices may be utilized for patients at risk for hypoglycemia similarly to the way that we use cardiac telemetry to monitor hospitalized patients who are at increased risk for cardiac arrhythmias.
PURPOSE OF THE REVIEW: Hospitalized patients with diabetes are monitored with point-of-care glucose testing. Continuous glucose monitoring (CGM) devices represent an alternative way to monitor glucose values; however, the in-hospital CGM use is still considered experimental. Most inpatient studies used "blinded" CGM properties and only few used the real-time/unblinded CGM features. One major limitation of the CGM devices is that they need to be placed at the patients' bedside, limiting any therapeutic interventions. In this article, we review the real-time/unblinded CGM use and share our thoughts about the development of future inpatient CGM systems. RECENT FINDINGS: We recently reported that glucose values can be wirelessly transmitted to the nursing station, providing remote continuous glucose monitoring. Future inpatient CGM devices may be utilized for patients at risk for hypoglycemia similarly to the way that we use cardiac telemetry to monitor hospitalized patients who are at increased risk for cardiac arrhythmias.
Authors: Amisha Wallia; Guillermo E Umpierrez; Robert J Rushakoff; David C Klonoff; Daniel J Rubin; Sherita Hill Golden; Curtiss B Cook; Bithika Thompson Journal: J Diabetes Sci Technol Date: 2017-04-21
Authors: Luc A Foubert; Patrick V Lecomte; Frank R Nobels; Angela M Gulino; Koen H De Decker Journal: Diabetes Technol Ther Date: 2014-08-05 Impact factor: 6.118
Authors: Finlay A McAlister; Sumit R Majumdar; Sandra Blitz; Brian H Rowe; Jacques Romney; Thomas J Marrie Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112
Authors: Jean-Charles Preiser; J Geoffrey Chase; Roman Hovorka; Jeffrey I Joseph; James S Krinsley; Christophe De Block; Thomas Desaive; Luc Foubert; Pierre Kalfon; Ulrike Pielmeier; Tom Van Herpe; Jan Wernerman Journal: J Diabetes Sci Technol Date: 2016-11-01
Authors: Grant V Bochicchio; Stan Nasraway; Laura Moore; Anthony Furnary; Eden Nohra; Kelly Bochicchio Journal: J Trauma Acute Care Surg Date: 2017-06 Impact factor: 3.313
Authors: Roy W Beck; Tonya Riddlesworth; Katrina Ruedy; Andrew Ahmann; Richard Bergenstal; Stacie Haller; Craig Kollman; Davida Kruger; Janet B McGill; William Polonsky; Elena Toschi; Howard Wolpert; David Price Journal: JAMA Date: 2017-01-24 Impact factor: 56.272
Authors: Ana M Gómez; Guillermo E Umpierrez; Oscar M Muñoz; Felipe Herrera; Claudia Rubio; Pablo Aschner; Richard Buendia Journal: J Diabetes Sci Technol Date: 2015-08-31
Authors: Antje Gottschalk; Henryk A Welp; Laura Leser; Christian Lanckohr; Carola Wempe; Björn Ellger Journal: PLoS One Date: 2016-03-10 Impact factor: 3.240
Authors: Lakshmi G Singh; David L Levitt; Medha Satyarengga; Lillian Pinault; Min Zhan; John D Sorkin; Jeffrey C Fink; Guillermo E Umpierrez; Elias K Spanakis Journal: J Diabetes Sci Technol Date: 2019-11-28
Authors: Lakshmi G Singh; Medha Satyarengga; Isabel Marcano; William H Scott; Lillian F Pinault; Zhaoyong Feng; John D Sorkin; Guillermo E Umpierrez; Elias K Spanakis Journal: Diabetes Care Date: 2020-08-05 Impact factor: 19.112